Cephalon Provigil Generics Settlements Under FTC Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC seeking information on four deals that postpone generic entry.
You may also be interested in...
Cephalon Earnings Beat Consensus, But Opinion Split On Future
"Sentiment-driven" stock due for growth year, analyst tells "The Pink Sheet" DAILY
Cephalon Earnings Beat Consensus, But Opinion Split On Future
"Sentiment-driven" stock due for growth year, analyst tells "The Pink Sheet" DAILY
FDA Approves Cephalon’s Nuvigil With Bolded Warning For Rash
Company tells “The Pink Sheet” DAILY it is set to begin studies in other therapeutic areas to boost labeling before commercial launch.